Resource Center

Downloads and answers to frequently asked questions about OcuTap.

Downloads

Clinical resources

  • Restricted PDF document

    Device specifications

    Detailed engineering and performance specifications. Contains proprietary information and is shared by request rather than published. Request permission and we'll add your email with viewing permission, then send you the link.

Fact sheet, team bios, and brand assets are shared together as one request. Request permission and we'll add your email with viewing permission, then send you the link.

  • Restricted PDF document

    Fact sheet

    Device specifications and technical performance data.

    Included in the Press kit request

  • Restricted ZIP file

    Team bios

    Headshots and professional bios for the full Visionaire team.

    Included in the Press kit request

  • Restricted ZIP file

    Brand assets

    High-resolution device photography, logos, and brand identity files.

    Included in the Press kit request

Videos and renders

FAQ

Intended-use disclaimer: OcuTap is intended only for the collection of aqueous humor from the anterior chamber using a standard anterior chamber paracentesis procedure by trained ophthalmologists. Following successful collection and transfer, all specimen handling, storage, transport, testing, analysis, reporting, and disposal are the responsibility of the user and/or receiving laboratory. Visionaire Products assumes no liability for events occurring after specimen collection and transfer, or for any use outside this intended use.

Stay informed on OcuTap’s regulatory progress.

OcuTap is pending FDA clearance, anticipated by the end of 2026. Sign up to get updates and we’ll email you when there’s meaningful news to share.

CAUTION—Investigational device. Limited by Federal law to investigational use. FDA 510(k) clearance anticipated by the end of 2026.

By clicking Get updates you’re confirming that you agree with our Terms of use.

REFERENCES & CITATIONS
  1. Regulatory classification and anticipated 510(k) clearance referenced throughout the FAQ.U.S. Food and Drug Administration. Ophthalmic device classification, 21 CFR 880.5570, Class II, product code QYL.
  2. 40 µL/second draw rate and 32-gauge needle specification.Visionaire Products, Inc. (2025). Evaluation of a Novel Single-Handed Microfluidic Device: Quantitative Performance and Key Opinion Leader (KOL) Advisory Assessment [Commercial Assessment Report]. Data on file.
  3. Clinician-reported barriers to the current standard of care.Visionaire Products, Inc. (2024). Clinician Sentiment and Barriers to Standard Ocular Paracentesis: A Double-Blind Specialist Survey [Unpublished Internal Report]. Data on file.